Waldencast PLC (NASDAQ:WALD) Receives Consensus Rating of "Moderate Buy" from Analysts

Waldencast PLC (NASDAQ:WALD - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven analysts that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among analysts that have covered the stock in the last year is $4.9714.

A number of brokerages have recently commented on WALD. Telsey Advisory Group dropped their price objective on shares of Waldencast from $4.00 to $3.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 20th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Waldencast in a report on Wednesday, October 8th.

Waldencast Trading Up 1.1%

Shares of NASDAQ:WALD opened at $1.88 on Tuesday. Waldencast has a twelve month low of $1.48 and a twelve month high of $4.18. The company's 50 day moving average is $1.81 and its 200 day moving average is $2.25.

Hedge Funds Weigh In On Waldencast

Several institutional investors have recently made changes to their positions in the company. Rhumbline Advisers lifted its holdings in Waldencast by 15.2% in the 1st quarter. Rhumbline Advisers now owns 61,630 shares of the company's stock valued at $185,000 after purchasing an additional 8,151 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Waldencast by 57.9% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 23,130 shares of the company's stock valued at $57,000 after purchasing an additional 8,485 shares in the last quarter. Invesco Ltd. purchased a new position in Waldencast in the 2nd quarter valued at $26,000. Police & Firemen s Retirement System of New Jersey purchased a new position in Waldencast in the 2nd quarter valued at $26,000. Finally, McAdam LLC purchased a new position in Waldencast in the 2nd quarter valued at $56,000. 41.97% of the stock is owned by hedge funds and other institutional investors.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.